NEW YORK (GenomeWeb News) — The University of Pittsburgh Medical School will serve as the alpha test site for Wafergen Biosystem’s real-time PCR system, Wafergen said today.
Through a research collaboration with a team led by Department of Medicine Chairman Steven Shapiro, the school will use the WaferGen SmartChip Real-Time PCR System in its efforts to identify biomarkers that are therapeutically useful for chronic obstructive pulmonary disease and for lung cancer.
Wafergen said the SmartChip “is designed as the first whole-genome, high-throughput gene expression real-time polymerase chain reaction platform.”
Financial terms of the collaboration were not released.